Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters
Introduction
Prostate cancer is the most common solid-organ cancer of men in Western countries and follows lung cancer as the second most frequent cancer-related cause of death. Among all malignant urological tumours, prostate cancer is the leading cause of death.1, 2 Despite its high incidence, the prognosis for patients with prostate cancer is excellent when the carcinoma is detected at a stage when curative treatments, like prostatectomy or radiation therapy, can be implemented.
Prostate cancer cells express several tumour-associated antigens, like PSMA. Nevertheless, the immune response against prostate cancer is inefficient. Investigating tumour-infiltrating lymphocytes is an important strategy to improve our understanding about immunological events that occur in the tumour environment. Infiltration of lymphocytes has been described for a number of solid tumours.3, 4 The infiltration of lymphocytes into the tumour microenvironment seems to play a role in anti-tumour immunity.5 Furthermore, infiltrating lymphocytes have been associated with prognosis in some cancer patients. In colorectal cancer, for instance, a low density of CD3+ infiltrating lymphocytes was associated with reduced survival time compared to patients with a high density of CD3+ infiltrating lymphocytes.6 Despite the presence of infiltrating lymphocytes, the question remains why efficient tumour cell elimination does not occur.
CD4+ CD25+ T cells are consistently observed among the total CD4+ lymphocyte population in mice and humans. These cells have been associated with regulatory activity in immune responses in both species. The leading function of regulatory T cells (Tregs) is to control immune recognition to self-antigens, thereby preventing autoimmunity.7, 8 Tregs have also been seen in human cancers. Nevertheless, their role in cancer pathogenesis is not yet clarified, and has become a central focus of research during the past several years.9, 10
A second form of immune suppression can be mediated by the PD-1-receptor and its ligand B7-H1.11 The presence of PD-1 or B7-H1 was associated with disease progression in chronic viral infections in mice and in HIV-infected individuals.12, 13 Moreover, PD-1-deficient mice developed autoimmune diseases.14 Thus, the expression of PD-1 and B7-H1 plays an important role in immune regulation.
In this study, freshly resected prostate carcinoma tissues, benign prostatic hyperplasia (BPH) and healthy prostate gland tissues were analysed for the presence of regulatory T lymphocyte markers using antibodies CD25 and FOXP3, as well as PD-1 and B7-H1.
We had previously described a clustered accumulation of CD3+ and CD4+ lymphocytes around prostate cancer islets with only few lymphocytes scattered within the tumour area. The lymphocytes were predominantly negative for perforin and IFNγ suggesting that they were functionally inactive.15 Now, we report that CD25+ and FOXP3+ cells are abundantly present within these lymphocyte clusters. Additionally, we document the presence of PD-1+ and B7-H1+ cells within the lymphocyte clusters. The presence of cells with negative immune regulatory activity and functionally exhausted cells may in part explain the previously observed quiescent lymphocyte phenotype. These findings together provide novel insight and a more detailed understanding of the in situ immune regulation to prostate cancer.
Section snippets
Human prostate tissue samples
Tissues were collected from 17 untreated patients who underwent radical curative prostatectomy (Department of Urology, Ludwig-Maximilians-University-Hospital, Munich). All prostate cancer samples showed histopathological evidence of prostate carcinoma with a differentiation grade of 6–9 according to Gleason (Table 1). Four tissues with BPH were collected from patients who underwent surgical adenoma resection (Table 2). Prostate tissues from eight healthy men were obtained from autopsies (Table 3
CD25+ lymphocytes reside in the lymphocyte clusters which surround prostate cancer areas
We had previously documented that pronounced clusters of CD3+ cells are formed adjacent to islets of tumour cells (for clarity documented in Fig. 1a and b).15 Within these lymphocyte clusters, CD4+ cells were the dominant cell type. There was no evidence for functional activity, defined by the absence of perforin and IFNγ, markers for cytotoxicity and effector function suggesting that these cells were quiescent.15
In this study, we report the presence of cells with negative regulatory function
Discussion
The aim of this study was to analyse prostate cancer tissues for the infiltration of T cells with negative immune regulatory capacity. During the past several years, more information about the negative regulatory function of a small subpopulation of CD4+ T lymphocytes expressing FOXP3 and CD25 have emerged. This small population was recognised to play a role in tolerance to self-antigens.7, 8 In various studies, the role of Tregs for cancer is discussed and the results seem to be similar,
Conflict of interest statement
None declared.
Acknowledgement
This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 455 and SFB-TR36).
References (30)
- et al.
Cancer statistics, 2007
CA Cancer J Clin
(2007) - et al.
International trends and patterns of prostate cancer incidence and mortality
Int J Cancer (Pred Oncol)
(2000) - et al.
Primary lung adenocarcinoma with massive lymphocyte infiltration
Am J Clin Pathol
(2005) - et al.
Colon cancer and the immune system: the role of tumor invading T cells
World J Gastroenterol
(2006) Progress in human tumour immunology and immunotherapy
Nature
(2001)- et al.
Type, density and location of immune cells within human colorectal tumours predict clinical outcome
Science
(2006) - et al.
Regulatory T cells in experimental autoimmune disease
Springer Semin Immunopathol
(2006) - et al.
Imbalance of regulatory T cells in autoimmune diseases
Immunology
(2006) - et al.
CD4 regulatory T cells in human cancer pathogenesis
Cancer Immunol Immunother
(2007) - et al.
Tumor-specific regulatory T cells in cancer patients
Human Immunol
(2008)
Immunology of B7-H1 and its roles in human diseases
Int J Hematol
Restoring function in exhausted CD8 T cells during chronic viral infection
Nature
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Nature
Autoimmune dilated cardiomyopathy in PD-1 receptor deficient mice
Science
Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma
Prostate
Cited by (116)
Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy
2023, Molecular Therapy Nucleic AcidsInteractions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications
2021, Critical Reviews in Oncology/HematologyThe Tumor Microenvironment and Immunotherapy in Prostate and Bladder Cancer
2020, Urologic Clinics of North AmericaPD-L1 overexpression in prostate cancer: a potential targeted therapy
2023, Bali Medical JournalProstate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers
2023, International Journal of Molecular Sciences